# XBiotech Inc. (XBIT)

> Source: Nexqual · https://nexqual.com/XBIT · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, XBiotech Inc. (XBIT), nexqual.com/XBIT" · informational, not investment advice.

**Price:** USD 2.16 (+0.00% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 2.16 · day 2.13–2.26 · 52w 2.09–3.44 · market cap $65.9M · NMS

## Key facts
- Analysts: None.
- Total return with dividends: 1Y -13.3% vs S&P 500 +18.1%; 5Y -83.7% vs S&P 500 +85.1%.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -13.3% | -83.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -13.3% | -30.3% |
| Volatility (annualized) | 43.8% | 60.2% |
| Max drawdown | -26.9% (Nov 2025→Sep 2026) | -86.4% (Nov 2021→Oct 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/XBIT · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt